---
schema_version: "secwatch.filing_event.v1"
accession: "0001097149-23-000054"
form_type: "8-K"
ticker: "ALGN"
cik: "0001097149"
company_name: "ALIGN TECHNOLOGY INC"
filed_at: "2023-07-26T23:59:59+00:00"
generated_at: "2026-06-13T02:12:59.368476+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Align Technology Q2 beats: rev $1.002B (+3.4% YoY), EPS $2.22, teen cases +10%

## Summary
- Q2 total revenues $1.002B, up 6.3% sequentially and 3.4% YoY; GAAP EPS $1.46, non-GAAP EPS $2.22.
- Clear Aligner teen volumes grew 7% sequentially and 10% YoY to 194.5K cases.
- Q2 operating margin 17.2% GAAP (21.3% non-GAAP); FY 2023 margin guidance raised ~1 point.
- Q3 revenue guidance $990M-$1,010M (+12% YoY midpoint); FY guidance $3.97B-$3.99B.
- Completed $75M equity investment in Heartland Dental; $1B stock repurchase authorization remains.

## SEC filing metadata
- accession: 0001097149-23-000054
- form_type: 8-K
- ticker: ALGN
- cik: 0001097149
- company_name: ALIGN TECHNOLOGY INC
- filed_at: 2023-07-26T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1097149/000109714923000054/0001097149-23-000054-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1097149/000109714923000054/algn-20230726.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001097149-23-000054
- JSON: https://secwatch.observer/filing/0001097149-23-000054.json
- Plain text: https://secwatch.observer/filing/0001097149-23-000054.txt

## Key facts
- Earnings Releases
  ALIGN TECHNOLOGY INC reported full year 2023 results: revenue we anticipate our 2023 WW Revenues to be in the range of $3.970B to $3.990B. Guidance raised.
  - Period: full year 2023
  - Revenue: we anticipate our 2023 WW Revenues to be in the range of $3.970B to $3.990B
  - Guidance: raised
  - Result: guidance update
  source text: For full year 2023, assuming no circumstances occur that are beyond our control, we anticipate our 2023 WW Revenues to be in the range of $3.970B to $3.990B.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1097149/000109714923000054/0001097149-23-000054-index.htm
- Earnings Releases
  ALIGN TECHNOLOGY INC reported second quarter ended June 30, 2023 results: revenue Q2'23 total revenues of $1.0 billion, increased 6.3% sequentially and 3.4% year-over-year, net income Q2'23 net income was $111.8 million, or $1.46 per diluted share, EPS $1.46.
  - Period: second quarter ended June 30, 2023
  - Revenue: Q2'23 total revenues of $1.0 billion, increased 6.3% sequentially and 3.4% year-over-year
  - Net income: Q2'23 net income was $111.8 million, or $1.46 per diluted share
  - EPS: $1.46
  - Result: reported results
  source text: ALIGN TECHNOLOGY ANNOUNCES SECOND QUARTER 2023 FINANCIAL RESULTS Better than expected revenues and operating margins reflect improving trends across regions Q2’23 Clear Aligner cases for teenagers increased 7% sequentially and 10% year over year, driven by momentum in both Submitters and Utilization and continued growth from Invisalign
  evidence_url: https://www.sec.gov/Archives/edgar/data/1097149/000109714923000054/0001097149-23-000054-index.htm
- Earnings Releases
  ALIGN TECHNOLOGY INC reported third quarter of 2023 results: revenue For Q3'23, we anticipate our WW Revenue to be in the range of $990M to $1,010M. Guidance raised.
  - Period: third quarter of 2023
  - Revenue: For Q3'23, we anticipate our WW Revenue to be in the range of $990M to $1,010M
  - Guidance: raised
  - Result: guidance update
  source text: For Q3'23, we anticipate our WW Revenue to be in the range of $990M to $1,010M, up approximately 12% year-over-year at the midpoint.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1097149/000109714923000054/0001097149-23-000054-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.